shutterstock-301050461
KONSTATIN TRONIN / SHUTTERSTOCK.COM
27 October 2015Asia-PacificGeordie Oldfield

Pharmaceutical trademarks: The smooth path to registration

In Australia, the selection and registration of pharmaceutical trademarks requires special attention. Examiners are much more likely to object to a trademark based on likelihood of causing deception or confusion if the application covers pharmaceuticals or related products. Furthermore, the increasingly crowded state of the trademark register mandates careful management. Nevertheless, consideration of the manner in which pharmaceuticals are distributed and sold can assist pharma trademark applicants in paving a path to registration and use in Australia.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
23 February 2023   New recruit joins from DLA Piper and will head up firm’s litigation team | Previously worked on Pfizer v Samsung Bioepis, Jusand v Rattlejack & Murray Engineering, and Pfizer v Sandoz | Follows prosecutor Chris Vindurampulle who joined in October last year.
Asia-Pacific
24 May 2022   The Federal Court of Australia has refused an appeal request in a decade-long case brought by Boehringer Ingelheim Animal Health against MSD subsidiary, Intervet International.
Asia-Pacific
30 November 2020   The Federal Court of Australia has granted Pfizer subsidiary Wyeth’s bid for an injunction against Merck Sharp Dohme in a dispute over vaccine patents.